Company intelligence / Profile preview

Aleris

Ownership: Private
Employees: ~5800
Development stage: Other

Overview

Aleris is one of Europe’s most renowned centers for bariatric surgery, having performed over 8,000 weight loss operations. Their clinical offering includes gastric bypass and sleeve gastrectomy surgeries for severe obesity. These procedures have demonstrated lasting weight loss and reduced risk of developing related diseases such as diabetes. Patients receive individualized assessment and follow-up care for two years post-surgery to support lifestyle changes.

Therapeutic areas: Metabolic DisordersEndocrinology
Modalities: DeviceNon-pharmacological therapy
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Aleris.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aleris.

Explore the full profile